يعرض 1 - 10 نتائج من 15 نتيجة بحث عن '"Sunil Narula"', وقت الاستعلام: 0.95s تنقيح النتائج
  1. 1
    Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent: A Phase 2 Measurable Residual Disease-Adapted Study

    المؤلفون: Benjamin A. Derman, Ankit Kansagra, Jeffrey Zonder, Andrew T. Stefka, David L. Grinblatt, Larry D. Anderson, Sandeep Gurbuxani, Sunil Narula, Shayan Rayani, Ajay Major, Andrew Kin, Ken Jiang, Theodore Karrison, Jagoda Jasielec, Andrzej J. Jakubowiak

    المصدر: JAMA oncology. 8(9)

    مصطلحات موضوعية: Male, Cancer Research, Neoplasm, Residual, Middle Aged, Antibodies, Monoclonal, Humanized, Imides, Dexamethasone, Oncology, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Multiple Myeloma, Lenalidomide, Proteasome Inhibitors

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e5c3a0fae97715447317653be822edcTest
    https://pubmed.ncbi.nlm.nih.gov/35862054Test


    أضف إلى المفضلة
  2. 2
    Supplementary Tables. from Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease

    المؤلفون: Hedy L. Kindler, Blase N. Polite, Chih-Yi Liao, Theodore Karrison, Yuan Ji, Murtuza Rampurwala, Sunil Narula, Paul Chang, Mitchell C. Posner, Kevin Roggin, Kiran Turaga, Oliver S. Eng, D. Kyle Hogarth, Uzma D. Siddiqui, John Hart, Shu-Yuan Xiao, Namrata Setia, Lindsay Alpert, Natalie Reizine, Bryan F. Peterson, Leah M. Chase, Samantha Lomnicki, Stephanie Moya, Daniel V.T. Catenacci

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56e0a1ced8f425acfcbaa028910185a2Test
    https://doi.org/10.1158/2159-8290.22535693.v1Test


    أضف إلى المفضلة
  3. 3
    Data from Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease

    المؤلفون: Hedy L. Kindler, Blase N. Polite, Chih-Yi Liao, Theodore Karrison, Yuan Ji, Murtuza Rampurwala, Sunil Narula, Paul Chang, Mitchell C. Posner, Kevin Roggin, Kiran Turaga, Oliver S. Eng, D. Kyle Hogarth, Uzma D. Siddiqui, John Hart, Shu-Yuan Xiao, Namrata Setia, Lindsay Alpert, Natalie Reizine, Bryan F. Peterson, Leah M. Chase, Samantha Lomnicki, Stephanie Moya, Daniel V.T. Catenacci

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::41f155c561001c259ea2dbc259cd251fTest
    https://doi.org/10.1158/2159-8290.c.6547916.v1Test


    أضف إلى المفضلة
  4. 4
    Supplmentary Figures from Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease

    المؤلفون: Hedy L. Kindler, Blase N. Polite, Chih-Yi Liao, Theodore Karrison, Yuan Ji, Murtuza Rampurwala, Sunil Narula, Paul Chang, Mitchell C. Posner, Kevin Roggin, Kiran Turaga, Oliver S. Eng, D. Kyle Hogarth, Uzma D. Siddiqui, John Hart, Shu-Yuan Xiao, Namrata Setia, Lindsay Alpert, Natalie Reizine, Bryan F. Peterson, Leah M. Chase, Samantha Lomnicki, Stephanie Moya, Daniel V.T. Catenacci

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::334c22bf17cef32bdb8faf4686f3c642Test
    https://doi.org/10.1158/2159-8290.22535690Test


    أضف إلى المفضلة
  5. 5
    Appendix.pdf from Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease

    المؤلفون: Hedy L. Kindler, Blase N. Polite, Chih-Yi Liao, Theodore Karrison, Yuan Ji, Murtuza Rampurwala, Sunil Narula, Paul Chang, Mitchell C. Posner, Kevin Roggin, Kiran Turaga, Oliver S. Eng, D. Kyle Hogarth, Uzma D. Siddiqui, John Hart, Shu-Yuan Xiao, Namrata Setia, Lindsay Alpert, Natalie Reizine, Bryan F. Peterson, Leah M. Chase, Samantha Lomnicki, Stephanie Moya, Daniel V.T. Catenacci

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ecf9d0ff43d9273e3067fea004435f5Test
    https://doi.org/10.1158/2159-8290.22535696Test


    أضف إلى المفضلة
  6. 6
    Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease

    المؤلفون: Leah Chase, Namrata Setia, Theodore Karrison, Samantha Lomnicki, D. Kyle Hogarth, Murtuza Rampurwala, Oliver S. Eng, Stephanie Moya, Blase N. Polite, Yuan Ji, Hedy L. Kindler, Bryan Peterson, Lindsay Alpert, Paul J. Chang, Daniel V.T. Catenacci, Natalie Reizine, John Hart, Uzma D. Siddiqui, Kiran K. Turaga, Chih-Yi Liao, Shu-Yuan Xiao, Mitchell C. Posner, Kevin K. Roggin, Sunil Narula

    المصدر: Cancer discovery, vol 11, iss 2

    مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Esophageal Neoplasms, medicine.medical_treatment, Phases of clinical research, Disease, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Monoclonal, 80 and over, Clinical endpoint, Molecular Targeted Therapy, Humanized, Cancer, Response rate (survey), Middle Aged, Progression-Free Survival, Treatment Outcome, Immunological, 5.1 Pharmaceuticals, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Biomarker (medicine), Female, Development of treatments and therapeutic interventions, Biotechnology, Adult, medicine.medical_specialty, Oncology and Carcinogenesis, Antineoplastic Agents, Adenocarcinoma, Antibodies, 03 medical and health sciences, Stomach Neoplasms, Internal medicine, medicine, Humans, Survival rate, Aged, Chicago, Chemotherapy, business.industry, Prevention, Evaluation of treatments and therapeutic interventions, Good Health and Well Being, 030104 developmental biology, business

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbb400806c99b45e3ab2a9d77b59065aTest
    https://doi.org/10.1158/2159-8290.cd-20-1408Test


    أضف إلى المفضلة
  7. 7
    Interim analysis of a phase 2 minimal residual disease (MRD)-adaptive trial of elotuzumab, carfilzomib, lenalidomide, and dexamethasone (Elo-KRd) for newly diagnosed multiple myeloma (MM)

    المؤلفون: Andrzej Jakubowiak, Bernadette Libao, Sunil Narula, Evangelia Andreatos, Brittany Wolfe, Jeffrey A. Zonder, Daniel Juergens, Ankit Kansagra, David L. Grinblatt, Michael R. Bishop, Ken Jiang, Amanda McIver, Jagoda Jasielec, Benjamin A. Derman, Luis Alcantar, Shayan Rayani, Theodore Karrison, Andrew T. Stefka, Sarah Major, Megan Whelan

    المصدر: Journal of Clinical Oncology. 39:8011-8011

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, medicine.drug_class, business.industry, Monoclonal antibody, medicine.disease, Interim analysis, Minimal residual disease, Carfilzomib, chemistry.chemical_compound, chemistry, Internal medicine, medicine, Elotuzumab, business, Dexamethasone, Multiple myeloma, medicine.drug, Lenalidomide

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::95a5f8a2611cca99d0bfd461527276c8Test
    https://doi.org/10.1200/jco.2021.39.15_suppl.8011Test


    أضف إلى المفضلة
  8. 8
    Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): Secondary and final primary efficacy analyses

    المؤلفون: Leah Chase, Namrata Setia, Lindsay Alpert, Anthony Serritella, Daniel V.T. Catenacci, Murtuza Rampurwala, Bryan Peterson, John Hart, Uzma D. Siddiqui, Chih-Yi Liao, Theodore Karrison, Natalie Reizine, Yuan Ji, Samantha Lomnicki, Blase N. Polite, Hedy L. Kindler, Sunil Narula

    المصدر: Journal of Clinical Oncology. 38:4561-4561

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Gastroesophageal adenocarcinoma, biology, business.industry, Metastatic tumor, Molecular heterogeneity, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, biology.protein, Antibody, business, 030215 immunology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e3b03615c8742ec325200f5dbda9094eTest
    https://doi.org/10.1200/jco.2020.38.15_suppl.4561Test


    أضف إلى المفضلة
  9. 9
    Evaluation of the Association of Perioperative UGT1A1 Genotype–Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma

    المؤلفون: Samantha Lomnicki, Vivek N. Prachand, Kelly Moore, Mark K. Ferguson, John Hart, Chih-Yi Liao, Shu-Yuan Xiao, Robert de Wilton Marsh, Leah Chase, Lindsay Alpert, Steven Brad Maron, Namrata Setia, Kenisha Allen, Christine Racette, Mitchell C. Posner, Kevin K. Roggin, Kristin Kipping-Johnson, Bryan Peterson, Sunil Narula, Barbara Gordon, Kiran K. Turaga, Murtuza Rampurwala, Uzma D. Siddiqui, Theodore Karrison, Blase N. Polite, Hedy L. Kindler, Daniel V.T. Catenacci, Ugne Markevicius

    المصدر: JAMA Network Open. 3:e1921290

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Esophageal Neoplasms, Genotype, Nausea, Leucovorin, Phases of clinical research, Antineoplastic Agents, Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Irinotecan, Loading dose, Gastroenterology, Stomach Neoplasms, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Glucuronosyltransferase, Aged, Aged, 80 and over, business.industry, General Medicine, Perioperative, Middle Aged, Oxaliplatin, Positron-Emission Tomography, Vomiting, Female, Fluorouracil, medicine.symptom, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0800900211877511506502276343c80Test
    https://doi.org/10.1001/jamanetworkopen.2019.21290Test


    أضف إلى المفضلة
  10. 10
    Personalized ANtibodies for GastroEsophageal Adenocarcinoma (PANGEA): Primary efficacy analysis of the phase II platform trial (NCT02213289)

    المؤلفون: Lindsay Alpert, John Hart, Sunil Narula, Bryan Peterson, Leah Chase, Namrata Setia, Murtuza Rampurwala, Kelly Moore, Ugne Markevicius, Theodore Karrison, Samantha Lomnicki, Uzma D. Siddiqui, Chih-Yi Liao, Kiran K. Turaga, Daniel V.T. Catenacci, Kristen Kipping-Johnson, Blase N. Polite, Hedy L. Kindler, Yuan Ji, Mitchell C. Posner

    المصدر: Journal of Clinical Oncology. 38:356-356

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Gastroesophageal adenocarcinoma, biology, business.industry, Molecular heterogeneity, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, biology.protein, Antibody, business, 030215 immunology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::048fb34dc2bf2b18dd0fa35eb9e767c3Test
    https://doi.org/10.1200/jco.2020.38.4_suppl.356Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث